KFF found that insurers denied 12%-18% of standard prior authorization requests in 2025, with significant variation among insurers and gaps in transparency. The post KFF: Insurers Denied 12%-18% of Prior Authorization Requests in 2025 appeared first on MedCity News .
Migraine drugs developer Slate Medicines is going public in a reverse merger with Fulcrum Therapeutics. The biotech’s lead antibody drug blocks two novel migraine targets, offering the potential for better efficacy compared to other next-generation migraine drugs in R&D. The…
Sanofi, one of the Massachusetts' largest pharmaceutical employers, will lay off more than 200 workers there a year after acquiring Blueprint Medicines.
Eyepoint said patients given its experimental treatment for wet AMD failed to maintain vision with less frequent injections compared to a standard treatment.
(MedPage Today) -- U.S. kindergarten vaccination rates inched down again last year and the share of children with exemptions rose to an all-time high, according to federal data posted Monday. The fraction of kids exempted from vaccine requirements...
(MedPage Today) -- More than two dozen Democratic senators called on HHS Secretary Robert F. Kennedy Jr. to rescind recent grant cancellations by the Agency for Healthcare Research and Quality (AHRQ). "We write to express our profound concern...
(MedPage Today) -- Early antiviral therapy at home for kids with influenza lowered the risk of related hospitalization, a retrospective case-control study from Taiwan indicated. Among 1,492 children, receiving antiviral therapy within 48 hours...
(MedPage Today) -- Vaccination was highly effective at preventing death in children hospitalized with acute gastroenteritis caused by rotavirus infection, but its impact on mortality when rotavirus wasn't the culprit was less certain, according...
(MedPage Today) -- Congo's fast-moving Ebola outbreak has now killed over 2,300 people and become the deadliest outbreak of the disease on record in the Central African nation. The outbreak unfolding in one of Congo's most vulnerable regions is...
(MedPage Today) -- Frailty worsened more for individuals with osteoarthritis (OA) affecting two or more joints versus those with single-joint or no OA, data from a long-running, population-based study indicated. Among more than 1,000 participants...
(MedPage Today) -- In my last column, I addressed why the Senate Homeland Security and Governmental Affairs Committee's decision to hold Anthony Fauci, MD, in contempt of Congress was legally flawed and procedurally unprecedented. But beyond the...
(MedPage Today) -- Not many allergists are mourning the exit of the first and only FDA-approved oral immunotherapy (OIT) product -- peanut allergy treatment Palforzia -- from the market. The standardized peanut protein product had been approved...